Margaroli Camilla, Horati Hamed, Garratt Luke W, Giacalone Vincent D, Schofield Craig, Dittrich A Susanne, Rosenow Tim, Dobosh Brian S, Lim Hong S, Frey Dario L, Veltman Mieke, Silva George L, Brown Milton R, Schultz Carsten, Tiddens Harm A W M, Ranganathan Sarath, Chandler Joshua D, Qiu Peng, Peng Limin, Scholte Bob J, Mall Marcus A, Kicic Anthony, Guglani Lokesh, Stick Stephen M, Janssens Hettie M, Tirouvanziam Rabindra
Department of Pediatrics, Center for CF & Airways Disease Research, Children's Healthcare of Atlanta, IMPEDE-CF Program, Emory University School of Medicine, Atlanta, GA, United States of America.
Department of Pediatrics, Div. of Respiratory Medicine and Allergology, I-BALL program, Erasmus MC-Sophia Children's Hospital, University Hospital Rotterdam, Rotterdam, The Netherlands.
J Cyst Fibros. 2022 Nov;21(6):967-976. doi: 10.1016/j.jcf.2022.06.001. Epub 2022 Jun 19.
Macrophages are the major resident immune cells in human airways coordinating responses to infection and injury. In cystic fibrosis (CF), neutrophils are recruited to the airways shortly after birth, and actively exocytose damaging enzymes prior to chronic infection, suggesting a potential defect in macrophage immunomodulatory function. Signaling through the exhaustion marker programmed death protein 1 (PD-1) controls macrophage function in cancer, sepsis, and airway infection. Therefore, we sought to identify potential associations between macrophage PD-1 and markers of airway disease in children with CF.
Blood and bronchoalveolar lavage fluid (BALF) were collected from 45 children with CF aged 3 to 62 months and structural lung damage was quantified by computed tomography. The phenotype of airway leukocytes was assessed by flow cytometry, while the release of enzymes and immunomodulatory mediators by molecular assays.
Airway macrophage PD-1 expression correlated positively with structural lung damage, neutrophilic inflammation, and infection. Interestingly, even in the absence of detectable infection, macrophage PD-1 expression was elevated and correlated with neutrophilic inflammation. In an in vitro model mimicking leukocyte recruitment into CF airways, soluble mediators derived from recruited neutrophils directly induced PD-1 expression on recruited monocytes/macrophages, suggesting a causal link between neutrophilic inflammation and macrophage PD-1 expression in CF. Finally, blockade of PD-1 in a short-term culture of CF BALF leukocytes resulted in improved pathogen clearance.
Taken together, these findings suggest that in early CF lung disease, PD-1 upregulation associates with airway macrophage exhaustion, neutrophil takeover, infection, and structural damage.
巨噬细胞是人类气道中的主要常驻免疫细胞,可协调对感染和损伤的反应。在囊性纤维化(CF)中,中性粒细胞在出生后不久就被募集到气道,并在慢性感染之前主动分泌具有破坏性的酶,这表明巨噬细胞免疫调节功能可能存在缺陷。通过耗竭标志物程序性死亡蛋白1(PD-1)发出的信号控制癌症、脓毒症和气道感染中的巨噬细胞功能。因此,我们试图确定CF患儿巨噬细胞PD-1与气道疾病标志物之间的潜在关联。
收集了45名年龄在3至62个月的CF患儿的血液和支气管肺泡灌洗液(BALF),并通过计算机断层扫描对肺部结构损伤进行量化。通过流式细胞术评估气道白细胞的表型,同时通过分子检测评估酶和免疫调节介质的释放。
气道巨噬细胞PD-1表达与肺部结构损伤、嗜中性粒细胞炎症和感染呈正相关。有趣的是,即使在没有可检测到的感染的情况下,巨噬细胞PD-1表达也会升高,并与嗜中性粒细胞炎症相关。在模拟白细胞募集到CF气道的体外模型中,募集的中性粒细胞衍生的可溶性介质直接诱导募集的单核细胞/巨噬细胞上的PD-1表达,这表明CF中嗜中性粒细胞炎症与巨噬细胞PD-1表达之间存在因果关系。最后,在CF BALF白细胞的短期培养中阻断PD-1可改善病原体清除。
综上所述,这些发现表明,在早期CF肺部疾病中,PD-1上调与气道巨噬细胞耗竭、中性粒细胞占优势、感染和结构损伤相关。